Royalty Pharma

NASDAQ: RPRX · Real-Time Price · USD
35.09
0.25 (0.72%)
At close: Jun 16, 2025, 3:59 PM
34.00
-3.11%
After-hours: Jun 16, 2025, 07:57 PM EDT

Royalty Pharma Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for RPRX stock have an median target of 51, with a low estimate of 40 and a high estimate of 51. The median target predicts an increase of 45.34% from the current stock price of 35.09.

Target Low Average Median High
Price 40 47.33 51 51
Change 13.99% 34.88% 45.34% 45.34%

Latest Analyst Insight Report

According to 3 stock analyst, the rating for Royalty Pharma is "Buy". This means that the analyst believes this stock is likely to lead to higher returns than market as a whole.

Rating Jul 24 Aug 24 Oct 24
Strong Buy 010
Buy 101
Hold 000
Sell 000
Strong Sell 000
Total 1 1 1

Financial Forecast this Year

Revenue This Year
2.98B
from 2.26B
Increased by 31.7%
Revenue Next Year
3.17B
from 2.98B
Increased by 6.4%
EPS This Year
4.41
from 1.92
Increased by 129.7%
EPS Next Year
5.03
from 4.41
Increased by 14.1%